Shilpa Medicare Unit VI Bengaluru facility receives Saudi Arabian GMP certification
Advertisement
Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification.
This follows the on-site inspection of this Site from 18 – 20th Feb 2025.
This was a full GMP inspection of entire facility with specific focus on Ondansetron Oral Film drug product.
The inspection was closed with ZERO observations.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.